Richa Poddar - 18 Feb 2022 Form 4 Insider Report for AGIOS PHARMACEUTICALS, INC. (AGIO)

Role
Chief Commercial Officer
Signature
/s/ William Cook, as Attorney in Fact for Richa Poddar
Issuer symbol
AGIO
Transactions as of
18 Feb 2022
Net transactions value
-$21,577
Form type
4
Filing time
23 Feb 2022, 15:11:43 UTC
Previous filing
16 Feb 2022
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AGIO Common stock Options Exercise $0 +1,884 +71% $0.000000 4,525 18 Feb 2022 Direct
transaction AGIO Common stock Options Exercise $0 +658 +15% $0.000000 5,183 22 Feb 2022 Direct
transaction AGIO Common stock Tax liability $21,577 -742 -14% $29.08 4,441 22 Feb 2022 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AGIO Performance share units Options Exercise $0 -1,884 -50% $0.000000 1,883 18 Feb 2022 Common stock 1,884 Direct F1, F2
transaction AGIO Restricted stock units Options Exercise $0 -658 -100% $0.000000* 0 22 Feb 2022 Common stock 658 Direct F3, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each performance share unit represents a contingent right to receive one share of the issuer's common stock.
F2 The PSUs vest as to one-third of the underlying shares of common stock, upon the achievement of each of three specified research, regulatory and commercial milestones, subject to continued service. The performance criteria for the specified regulatory milestone was determined to have been met on February 18, 2022, resulting in the vesting of the PSUs as to one-third of the underlying shares of common stock on that date. Vested shares will be delivered to the reporting person within three business days after such shares become vested.
F3 Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4 The restricted stock units were granted on February 22, 2019. Beginning on February 22, 2020, the shares underlying the restricted stock units will vest in three equal annual installments.